Abstract: The objective of the invention is to provide a plant activator with superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination. A plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1-8 mg/L, and a method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L. A method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L.

Abstract: The objective of the invention is to provide a plant activator with superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination. A plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1-8 mg/L, and a method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L. A method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L.

Abstract: The present invention relates to a medicament for treating and/or preventing inflammatory bowel disease, comprising a quinolone compound of the formula shown below as an active ingredient.

Abstract: The objective of the invention is to provide a plant activator with superior resistance-inducing activity and growth promoting activity and low toxicity and soil contamination. A plant activator comprising a fatty acid metabolite obtainable by a metabolism of a fatty acid with 4 to 30 carbon atoms by a proteobacteria under a dissolved oxygen concentration of 0.1-8 mg/L, and a method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L. A method for manufacturing a plant activator comprising a fatty acid metabolite, comprising a step for fatty acid metabolism wherein a fatty acid with 4 to 30 carbon atoms is subjected to a proteobacterial metabolization under a dissolved oxygen concentration of 0.1-8 mg/L.

Abstract: The present invention relates to novel substituted benzyloxy-phenylmethylamide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1 (CMR-1) activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor oeractivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD).

Abstract: The present invention relates to the use of 2,5-diamidoindole derivatives for the preparation of medicaments for treating urological disorders in humans and/or animals.